473 related articles for article (PubMed ID: 11712388)
1. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
2. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
5. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
Shigeto E; Murakami I; Yokosaki Y
Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
[TBL] [Abstract][Full Text] [Related]
6. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
7. Abnormal thyroid function tests in children on ethionamide treatment.
Thee S; Zöllner EW; Willemse M; Hesseling AC; Magdorf K; Schaaf HS
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1191-3, i. PubMed ID: 21943844
[TBL] [Abstract][Full Text] [Related]
8. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
9. Para-aminosalicylic acid (PAS) desensitization review in a case of multidrug-resistant pulmonary tuberculosis.
Wilson JW; Kelkar P; Frigas E
Int J Tuberc Lung Dis; 2003 May; 7(5):493-7. PubMed ID: 12757053
[TBL] [Abstract][Full Text] [Related]
10. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
11. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
[TBL] [Abstract][Full Text] [Related]
12. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
Reichlin S; Frei R; Reusser P
Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
[TBL] [Abstract][Full Text] [Related]
14. [A case of multi-drug resistant pulmonary tuberculosis after administration of standard anti-tuberculosis treatment for two times].
Wakabayashi K; Yano S; Kobayashi K; Tokuda Y; Ikeda T; Ishikawa S; Takeyama H
Kekkaku; 2008 Jul; 83(7):513-7. PubMed ID: 18709969
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
16. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
Ogawara M; Sakatani M
Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
[TBL] [Abstract][Full Text] [Related]
17. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
19. High rate of hypothyroidism among patients treated for multidrug-resistant tuberculosis in Lesotho.
Satti H; Mafukidze A; Jooste PL; McLaughlin MM; Farmer PE; Seung KJ
Int J Tuberc Lung Dis; 2012 Apr; 16(4):468-72. PubMed ID: 22326109
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant tuberculosis: response to treatment.
Saenghirunvattana S; Charoenpan P; Vathesatogkit P; Kiatboonsri S; Aeursudkij B
J Med Assoc Thai; 1996 Sep; 79(9):601-3. PubMed ID: 8996991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]